Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Glaucoma Medication Adherence

Glaucoma Medication Adherence EDITORIAL Room for Improvement in Both Performance and Measurement LAUCOMA IS THE LEADING CAUSE OF IR- a sample medication as prescribed but never filled the 1,2 reversible blindness worldwide and the prescription for the medication when the sample ran out number of Americans with glaucoma is would be nonpersistent. Previously, the term compli- expected to increase by 50% in the next ance was often used to describe how well a patient fol- G 15 years. Multiple clinical trials have lowed physician instructions. The terms adherence and shown that with effective medical treatment, much (but persistence have largely replaced compliance as more spe- 4-6 not all) vision loss can be prevented. Whether mea- cific terms for describing the often complex relation- 7 8,9 sured by pharmacy data, self-report, or medication ship between prescribed and actual medication use. monitor, adherence to glaucoma medication is often poor. Investigators studying medication adherence have COMPONENTS OF MEDICATION ADHERENCE identified multiple factors related to poor adherence, in- 11 12 cluding more frequent and complex dosing and situ- Once a patient accepts that medical therapy is indi- ational factors, such as competing activities and for- cated, proper adherence to a prescribed glaucoma medi- getfulness, as well http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Glaucoma Medication Adherence

JAMA Ophthalmology , Volume 129 (2) – Feb 1, 2011

Loading next page...
 
/lp/american-medical-association/glaucoma-medication-adherence-qms0GUy9y5
Publisher
American Medical Association
Copyright
Copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/archophthalmol.2010.351
pmid
21320975
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL Room for Improvement in Both Performance and Measurement LAUCOMA IS THE LEADING CAUSE OF IR- a sample medication as prescribed but never filled the 1,2 reversible blindness worldwide and the prescription for the medication when the sample ran out number of Americans with glaucoma is would be nonpersistent. Previously, the term compli- expected to increase by 50% in the next ance was often used to describe how well a patient fol- G 15 years. Multiple clinical trials have lowed physician instructions. The terms adherence and shown that with effective medical treatment, much (but persistence have largely replaced compliance as more spe- 4-6 not all) vision loss can be prevented. Whether mea- cific terms for describing the often complex relation- 7 8,9 sured by pharmacy data, self-report, or medication ship between prescribed and actual medication use. monitor, adherence to glaucoma medication is often poor. Investigators studying medication adherence have COMPONENTS OF MEDICATION ADHERENCE identified multiple factors related to poor adherence, in- 11 12 cluding more frequent and complex dosing and situ- Once a patient accepts that medical therapy is indi- ational factors, such as competing activities and for- cated, proper adherence to a prescribed glaucoma medi- getfulness, as well

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Feb 1, 2011

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month